- Drugs, Vaccines,
- Feed Additives
The USA Animal Healthcare Market size was valued at USD 18,648.2 million in 2021 and is expected to grow at a significant CAGR of 8.4% during the forecast period from 2022 to 2028. The report provides a detailed overview of the market and that can be segmented By Product type, animal type, route of administration, and distribution channel. By Product type, the USA animal healthcare market has been segmented into drugs, vaccines, and feed additives. The Drugs segment is likely to be the largest and fastest-growing segment in terms of product type. Based on animal type, the market is segmented into Farm Animals, Companion Animals, and Aquaculture. Among these, the farm animals’ segment is expected to have the fastest-growing market during the forecast period 2022-2028.  Based on route of administration, the USA animal healthcare market is segmented into Oral, Parenteral, Topical, and Others. The oral segment is expected to dominate the market in the future. Based on the distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, veterinary pharmacies, and e-commerce. The veterinary Hospitals segment is expected to grow at the highest CAGR over the forecast years according to Precision Business Insights. Key Development: In February 2021, Merck Animal Health acquired Poultry Sense Limited, expanding its poultry product line. In July 2020, Merck Animal Health doubled its animal vaccine production capacity in its Kansas manufacturing facility by USD 100 million.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The growing prevalence of diseases among animals is creating lucrative opportunities for the growth of the global animal health care market during the forecast period. Moreover, rise in R&D for the development and launch of newer products also immense boost to the market in the future.
The usa animal healthcare market is projected to expand at a CAGR of 8.4% during the forecast period
The major players in the global USA Animal Healthcare market are Boehringer Ingelheim GmbH (Germany), Cargill, Inc. (U.S), Ceva Santé Animale (France), Koninklijke DSM N.V. (Netherlands), Merck & Co., Inc. (U.S), Nutreco N.V. (Netherlands), Vétoquinol S.A. (France), Virbac S.A. (France), Zoetis Inc. (U.S), Elanco (U.S.).
1. Executive Summary |
2. USA Animal Healthcare Market Introduction |
2.1. USA Animal Healthcare Market – Taxonomy |
2.2. USA Animal Healthcare Market –Definitions |
2.2.1. Product Type |
2.2.2. Animal Type |
2.2.3. Route of Administration |
2.2.4. Distribution Channel |
3. USA Animal Healthcare Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. USA Animal Healthcare Market Dynamic Factors - Impact Analysis |
4. USA Animal Healthcare Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. USA Animal Healthcare Market, By Product Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1. Drugs |
5.1.1. Antibiotics |
5.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Antifungal |
5.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Ectoparasiticides |
5.1.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Endoparacitides |
5.1.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.1.5. Endectoparaciticides |
5.1.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.5.3. Market Opportunity Analysis |
5.1.6. Anti-inflammatory Drugs |
5.1.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.6.3. Market Opportunity Analysis |
5.1.7. Drugs for Chronic Diseases |
5.1.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.7.3. Market Opportunity Analysis |
5.1.8. Others |
5.1.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.8.3. Market Opportunity Analysis |
5.2. Vaccines |
5.2.1. Poultry Vaccines |
5.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Companion Animal Vaccines |
5.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Swine Vaccines |
5.2.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.2.4. Other Vaccines |
5.2.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
5.3. Feed Additives |
5.3.1. Nutritional Feed Additives |
5.3.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.1.3. Market Opportunity Analysis |
5.3.2. Medicinal Feed Additives |
5.3.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.2.3. Market Opportunity Analysis |
6. USA Animal Healthcare Market, By Animal Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1. Farm Animals |
6.1.1. Livestock |
6.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.1.3. Market Opportunity Analysis |
6.1.2. Poultry |
6.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.2.3. Market Opportunity Analysis |
6.1.3. Swine |
6.1.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3.3. Market Opportunity Analysis |
6.1.4. Equine |
6.1.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.4.3. Market Opportunity Analysis |
6.2. Companion Animals |
6.2.1. Feline |
6.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.1.3. Market Opportunity Analysis |
6.2.2. Canine |
6.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.2.3. Market Opportunity Analysis |
6.2.3. Avian |
6.2.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3.3. Market Opportunity Analysis |
6.3. Aquaculture |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. USA Animal Healthcare Market Forecast, By Route of Administration, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.1. Oral |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Parenteral |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Topical |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. USA Animal Healthcare Market Forecast, By Distribution Channel, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1. Veterinary Hospitals |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Veterinary Clinics |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Veterinary Pharmacies |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. E-Commerce |
8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. USA Animal Healthcare Market - Opportunity Analysis Index, By Product Type, Animal Type and Region, 2022 - 2028 |
9. Competition Landscape |
9.1. Strategic Dashboard of Top Market Players |
9.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
9.2.1. Boehringer Ingelheim GmbH (Germany) |
9.2.2. Cargill, Inc. (U.S) |
9.2.3. Ceva Santé Animale (France) |
9.2.4. Koninklijke DSM N.V. (Netherlands) |
9.2.5. Merck & Co., Inc. (U.S) |
9.2.6. Nutreco N.V. (Netherlands) |
9.2.7. Vétoquinol S.A. (France) |
9.2.8. Virbac S.A. (France) |
9.2.9. Zoetis Inc. (U.S) |
9.2.10. Elanco (U.S.) |
10. Research Methodology |
11. Key Assumptions and Acronyms |